Genolution has signed a memorandum of understanding (MOU) with Jaeneung University to foster talent specializing in the bio and medical diagnostics fields.


Genolution Signs MOU with Jaeneung University to Foster Talent in Bio and Diagnostics Fields View original image

According to Genolution on August 26, this agreement was initiated to maximize synergy between academia and industry by connecting Genolution’s molecular diagnostics technology and advanced platform research infrastructure with Jaeneung University's practical, job-focused educational capabilities.


The two institutions have agreed to actively collaborate in the following areas: ▲ joint development and operation of customized education programs in bio and diagnostic technology; ▲ employment support through on-site training and internship programs; ▲ joint research and development (R&D) and technical exchanges between industry and academia; and ▲ shared use of each institution's facilities and advanced research infrastructure.


Nam Sik Lee, President of Jaeneung University, stated, "We are honored to partner with Genolution, a leading domestic company in molecular diagnostics and bio-platform technologies. Based on this agreement, we will provide students with advanced, practical education to directly experience cutting-edge industry technologies and will actively support their growth into key talents who will lead the future bio industry."



Min Yi Kim, CEO of Genolution, said, "Through industry-academia collaboration with Jaeneung University, which is at the forefront of practical, career-focused educational innovation, we will spare no effort to provide multifaceted support so that outstanding young talents with potential can develop substantial research and practical capabilities. Moving forward, we aim to establish an innovative model of collaboration between universities and corporations for mutual advancement."


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing